Related references
Note: Only part of the references are listed.nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
David Goldstein et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
David Goldstein et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
Chunning Zheng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Postoperative Complications Deteriorate Long-Term Outcome in Pancreatic Cancer Patients
Carsten Kamphues et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Downregulation of BCL2 by miRNAs augments drug-induced apoptosis - a combined computational and experimental approach
Richa Singh et al.
JOURNAL OF CELL SCIENCE (2012)
Gatifloxacin Induces S and G2-Phase Cell Cycle Arrest in Pancreatic Cancer Cells via p21/p27/p53
Vikas Yadav et al.
PLOS ONE (2012)
Ciprofloxacin and Epirubicin Synergistically Induce Apoptosis in Human Urothelial Cancer Cell Lines
Daniel S. Engeler et al.
UROLOGIA INTERNATIONALIS (2012)
Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability
Naihan Xu et al.
JOURNAL OF ONCOLOGY (2012)
Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
Philip Q. Bao et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells
Yogita K. Adlakha et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells
Tsung-Ying Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Overcoming drug resistance in pancreatic cancer
Jiang Long et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Small Interfering RNA against Transcription Factor STAT6 Leads to Increased Cholesterol Synthesis in Lung Cancer Cell Lines
Richa Dubey et al.
PLOS ONE (2011)
Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors
Debby Reuveni et al.
BIOCHEMICAL PHARMACOLOGY (2010)
ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
Sebastien Cagnol et al.
FEBS JOURNAL (2010)
Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-β1 secretion and enhances the anti-proliferative effect of 5-fluorouracil
Leonidas A. Bourikas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: Role of NF-κB, Akt, ROS and MAP kinase pathway
Anita Goel et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Cyclin-dependent kinases: a family portrait
Marcos Malumbres et al.
NATURE CELL BIOLOGY (2009)
The Recognition and Surgical Management of Heritable Lesions of the Pancreas
Michael P. Kim et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects
Debby Reuveni et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Apoptosis: controlled demolition at the cellular level
Rebecca C. Taylor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-κB activation in a cystic fibrosis epithelial cell line
Hannah Blau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential
Dong Xiao et al.
CARCINOGENESIS (2006)
Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells
I. Fabian et al.
BRITISH JOURNAL OF CANCER (2006)
Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate
Annarica Calcabrini et al.
CARCINOGENESIS (2006)
Prolonged activation of ERK1, 2 induces FADD-independent caspase 8 activation and cell death
S Cagnol et al.
APOPTOSIS (2006)
Immunomodulatory activities of fluoroquinolones
A Dalhoff
INFECTION (2005)
Ciprofloxacin-induced cytotoxicity and apoptosis in HeLa cells
A Gürbay et al.
TOXICOLOGY MECHANISMS AND METHODS (2005)
Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells
YL Hsu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Mitogen-activated protein kinases in apoptosis regulation
T Wada et al.
ONCOGENE (2004)
AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2
BN Fahy et al.
BRITISH JOURNAL OF CANCER (2003)
Leptin induces apoptosis via ERK/cPLA2/cytochrome C pathway in human bone marrow stromal cells
GS Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Decision making by p53: life, death and cancer
M Oren
CELL DEATH AND DIFFERENTIATION (2003)
ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53
DM Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells
C Herold et al.
BRITISH JOURNAL OF CANCER (2002)
Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide
FG Araujo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2002)
Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
MC Wei et al.
SCIENCE (2001)
Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways
A Suliman et al.
ONCOGENE (2001)
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
SS Bacus et al.
ONCOGENE (2001)
Requirement for ERK activation in cisplatin-induced apoptosis
XT Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
V Heinemann et al.
ANNALS OF ONCOLOGY (2000)
Long-term survival after multimodality treatment for resectable pancreatic cancer
H Ozaki et al.
INTERNATIONAL JOURNAL OF PANCREATOLOGY (2000)
Share Paper
